ProFund Advisors »

Crinetics Pharmaceuticals In shares owned by ProFund Advisors

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 34k 46.81
2023-09-30 $1.0M 34k 29.74
2023-06-30 $461k 26k 18.02
2023-03-31 $392k 24k 16.06

More positions owned by ProFund Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Qualcomm (QCOM)
Intel Corporation (INTC)
Costco Wholesale Corporation (COST)
Applied Materials (AMAT)
Netflix (NFLX)

View all positions for ProFund Advisors

Top funds holding Crinetics Pharmaceuticals In

BlackRock
Point72 Asset Management
FMR
EcoR1 Capital
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Paradigm Biocapital Advisors
Jennison Associates
T. Rowe Price Investment Management
Henderson Group
First Light Asset Management
Perceptive Advisors
Geode Capital Management
Artal Group

View all funds holding Crinetics Pharmaceuticals In